Pharmab, Inc.
Records under this name other than the patents Pharmab, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 6 of 6 · Back to Pharmab, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,637,637 | Fc fusion proteins of human growth hormone Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,655,292 | Anti-Human NGF Antibodies and Methods Using Same Formerly held In force · High confidence | In force | High confidence | |
| US 6,900,292 | Fc fusion proteins of human erythropoietin with increased biological activities Formerly held Term ended Term ended Jun 4, 2022 · From the USPTO record | Term ended | Term ended Jun 4, 2022 | From the USPTO record |
| US 6,797,493 | Fc fusion proteins of human granulocyte colony-stimulating factor with increased biological activities Term ended Term ended May 4, 2022 · From the USPTO record | Term ended | Term ended May 4, 2022 | From the USPTO record |
| US 7,232,668 | Fc fusion proteins of human granulocyte colony-stimulating factor with increased biological activities Lapsed on the fee record Ended Jun 19, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jun 19, 2019 | From the USPTO record |
| US 7,226,759 | Fc fusion proteins of human granulocyte colony-stimulating factor with increased biological activities Lapsed on the fee record Ended Jun 5, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jun 5, 2019 | From the USPTO record |